JPRN-UMIN000019256尚未招募未知
The study of adherence and side effects of immunosuppression therapy after liver transplantation - Adherence and side effects of immunosupression after liver transplantation
Kyoto University Graduate School of Medicine0 个研究点目标入组 300 人开始时间: 2015年10月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have not received immunosuppressive drugs Patients who are not willing to participate in this study
研究者
相似试验
招募中
不适用
Research to inform the impact of immunosuppressive medications taken during pregnancy on maternal and infant immune responses to vaccinesACTRN12619001322123Associate Professor Nicholas Wood100
尚未招募
不适用
Blood Tests of Immunological Biomarkers can predict the outcomes of Cytoreductive Surgery (Complete Tumor and Tumor Deposit Removal) and Hyperthermic Intraperitoneal Chemotherapy (Heated Chemotherapy in the abdomen during Surgery), in Ovarian Cancer patientsCTRI/2023/01/049023il
已完成
不适用
Adherence and patients' experiences with the use of erlotinib in NSCLC treatment: The influence on plasma concentration and the exploration of factors affecting the use in daily practicenon-small-cell-lung cancer or lung cancer10038666NL-OMON33122Vrije Universiteit Medisch Centrum50
已完成
不适用
Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practicecolorectal cancergastric cancer and breast cancer10017991NL-OMON36444Vrije Universiteit Medisch Centrum90
招募中
3 期
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University.Assessing the immunological responses and adverse reactions elicited by the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccinationCOVID-19SAR-CoV-2 second booster doseheterologous vaccinationBNT162b2CoronaVachealthcare workersTCTR20221112001The National Science Research and Innovation Fund340